{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:50:46Z","timestamp":1781509846426,"version":"3.54.1"},"reference-count":89,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":613,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1046\/j.1440-1746.2000.02114.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:16:42Z","timestamp":1047446202000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Adverse effects and other safety aspects of the hepatitis C antivirals"],"prefix":"10.1111","volume":"15","author":[{"given":"Anuchit","family":"Chutaputti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260720"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040523"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80184-X"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212203"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007265"},{"key":"e_1_2_6_7_2","first-page":"177","article-title":"Hypertriglyceridemia following treatment with interferon alpha in essential thrombocythemia.","volume":"37","author":"De Salvo L","year":"1996","journal-title":"Invest. Clin."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80675-0"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/030089169207800515","article-title":"Hypertriglyceridemia during long\u2010term interferon\u2010alpha therapy: efficacy of diet and gemfibrosil treatment: a case report.","volume":"78","author":"Berruti A","year":"1992","journal-title":"Tumori"},{"key":"e_1_2_6_10_2","first-page":"542","article-title":"Severe hypertriglyceridemia during the course of treatment with interferon\u2010alpha in a patient with chronic hepatitis C (Letter).","volume":"19","author":"Bory E","year":"1996","journal-title":"Gastroenterol. Hepatol."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80113-9"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02355061"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370090055011"},{"key":"e_1_2_6_14_2","first-page":"1641","article-title":"Exacerbation of peripheral neuropathy during alpha\u2010interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection.","volume":"23","author":"La Civita L","year":"1996","journal-title":"J. Rheumatol."},{"key":"e_1_2_6_15_2","first-page":"980","article-title":"A case of myasthenia gravis which developed myasthenic crisis after alpha\u2010interferon therapy for chronic hepatitis C.","volume":"36","author":"Konishi T.","year":"1996","journal-title":"Rinsho Shinkeigaku (Clin. Neurol.)"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199212000-00002"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685955"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80185-1"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)93356-T"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90401-8"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90281-G"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6870.107"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91595-X"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90139-6"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220506"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80507-0"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90162-0"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02212711"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)91634-S"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609009156"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840100106"},{"key":"e_1_2_6_32_2","first-page":"491","article-title":"Thyrotropin receptor antibodies following treatment with recombinant alpha\u2010interferon in patients with hepatitis.","volume":"125","author":"Fonseca V","year":"1991","journal-title":"Acta Endocrinol."},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1320587"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1159\/000184606"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.6.855"},{"key":"e_1_2_6_36_2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/0016-5085(92)90348-3","article-title":"Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.","volume":"102","author":"Lisker\u2010Mekman M","year":"1992","journal-title":"Gastroenterology"},{"key":"e_1_2_6_37_2","volume-title":"Study Monitoring Data.","author":"Regulatory Affairs.","year":"1997"},{"key":"e_1_2_6_38_2","first-page":"399","article-title":"The risk factor for development of thyroid disease during interferon\u2010alpha therapy for chronic hepatitis C.","volume":"89","author":"Watanabe U","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_39_2","first-page":"244","article-title":"Development of thyroid autoimmunity after administration of recombinant human interferon\u2010alpha 2b for chronic viral hepatitis.","volume":"88","author":"Chung YW","year":"1993","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.751768.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb02423.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1993.tb02135.x"},{"key":"e_1_2_6_43_2","first-page":"714","article-title":"A case of drug\u2010induced immune hemolytic anemia during alpha\u2010interferon therapy for renal cell carcinoma.","volume":"87","author":"Yanaihara H","year":"1996","journal-title":"Nippon Hinyokika Gakkai Zasshi (Jpn J. Urol.)"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1994.tb00405.x"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470333"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830410215"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19911001)68:7<1536::AID-CNCR2820680713>3.0.CO;2-B"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80913-8"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(94)90124-4"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91744-S"},{"key":"e_1_2_6_51_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00400427","article-title":"Interferon\u2010alpha and IDDM (Letter & Comment).","volume":"39","author":"Foulis AK.","year":"1996","journal-title":"Diabetologia"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02065528"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609009156"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02087923"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.3.922"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90020-2"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90389-3"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.198"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.37.905"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1995.tb01528.x"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246208"},{"key":"e_1_2_6_62_2","first-page":"1176","article-title":"Canities and vitiligo complicating interferon therapy for hepatitis C.","volume":"90","author":"Bernstein D","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_63_2","first-page":"825","article-title":"Lichen planus and chronic hepatitis C: exacerbation of the lichen under interferon\u2010alpha\u20102a therapy.","volume":"8","author":"Areias J","year":"1996","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91029-H"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb14774.x"},{"key":"e_1_2_6_66_2","first-page":"1771","article-title":"Arthritis in a patient with psoriasis after interferon\u2010alpha therapy for chronic hepatitis C.","volume":"21","author":"Makino Y","year":"1994","journal-title":"J. Rheumatol."},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009749709065666"},{"key":"e_1_2_6_68_2","first-page":"1756","article-title":"Exacerbation of psoriasis due to interferon\u2010\u03b1 treatment of chronic active hepatitis.","volume":"88","author":"Georgetson MJ","year":"1993","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_69_2","first-page":"309","article-title":"Retinal complications during interferon therapy for chronic hepatitis C.","volume":"91","author":"Kawano T","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100080093034"},{"key":"e_1_2_6_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90237-2"},{"key":"e_1_2_6_72_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.3.939"},{"key":"e_1_2_6_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470330"},{"key":"e_1_2_6_74_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.33.337"},{"key":"e_1_2_6_75_2","first-page":"702A","article-title":"Single\u2010dose\/ tolerability and pharmacokinetic\/pharmacodynamics (PK\/PD) following administration of ascending subcutaneous doses of pegylated\u2010interferon and interferon alfa\u20102a to healthy subjects.","volume":"28","author":"Xu Z\u2010X","year":"1998","journal-title":"Hepatology"},{"key":"e_1_2_6_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.6.1139"},{"key":"e_1_2_6_77_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260231"},{"issue":"1","key":"e_1_2_6_78_2","first-page":"57","article-title":"Combination therapy with interferon alfa and ribavirin as retreatment of chronic hepatitis C.","volume":"19","author":"McHutchison JG","year":"1999","journal-title":"Semin. Liver Dis."},{"key":"e_1_2_6_79_2","first-page":"387A","article-title":"An international randomized trial of interferon alfa\u20102b and ribavirin (intron A\/rebetol) 48 or 24 weeks vs intron A 48 weeks for first line treatment of chronic hepatitis C.","volume":"28","author":"Poynard T","year":"1998","journal-title":"Hepatology"},{"key":"e_1_2_6_80_2","first-page":"387A","article-title":"Interferon alfa 2b alone or in combination with ribavirin in na\u00efve chronic HCV patients: a US multicenter trial.","volume":"28","author":"McHutchison J","year":"1998","journal-title":"Hepatology"},{"key":"e_1_2_6_81_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392102"},{"key":"e_1_2_6_82_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392101"},{"key":"e_1_2_6_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07124-4"},{"key":"e_1_2_6_84_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00702.x"},{"key":"e_1_2_6_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80103-1"},{"key":"e_1_2_6_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)06088-1"},{"key":"e_1_2_6_87_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.5.602"},{"issue":"1","key":"e_1_2_6_88_2","first-page":"67","article-title":"Safety of combination interferon alfa\u20102b\/ribavirin therapy in chronic hepatitis C\u2010relapsed and treatment\u2010na\u00efve patients.","volume":"19","author":"Maddrey WC.","year":"1999","journal-title":"Semin. Liver Dis."},{"key":"e_1_2_6_89_2","first-page":"371A","article-title":"Interferon and ribavirin associated retinopathy in patients with hepatitis C.","volume":"28","author":"Deep LS","year":"1998","journal-title":"Hepatology"},{"key":"e_1_2_6_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80154-8"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1746.2000.02114.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1046\/j.1440-1746.2000.02114.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:57:05Z","timestamp":1695733025000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1746.2000.02114.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":89,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["10.1046\/j.1440-1746.2000.02114.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1746.2000.02114.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]},"assertion":[{"value":"2002-01-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}